Where is Novartis headquartered?
In Basel, Switzerland.
Gain a deeper understanding of how Novartis is organized around the world. Founded in 1885, Novartis operates a network of 564 subsidiaries across 82 countries, with 153 in the United States (27.1%), 119 in India (21.1%), and 34 in Spain (6.0%). Together these three countries account for 54.3% of the companies owned by Novartis.
Novartis
Company Hierarchy
| Company | Location | Founded | Employees | Revenue (USD) | Legal Type | CEO | Website | Category Code | Category Description | # in Group | Local HQ Name | Local HQ City | Local HQ Country | National HQ Name | National HQ City | Global HQ Name | Global HQ City | Global HQ Country | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novartis AGNovartis AGGlobal Headquarter | Basilea, Switzerland | 1885 | 75,267 | $56.7B | Corporation | Vasant Kalathur Narasimhan | novartis.ch | 6719 | Offices of Holding Companies, Not Elsewhere Classified | 564 | Novartis AG | BASEL | Switzerland | Novartis AG | BASEL | Novartis AG | BASEL | Switzerland | ||
Novartis Pharma Canada INC.Novartis Pharma Canada INC.National HQ | Montréal, Canada | 1997 | 2,000 | $663.2M | Corporation | Mark Vineis | novartis.ca | 2834 | Pharmaceutical Preparations | 564 | Novartis AG | BASEL | Switzerland | Novartis Pharma Canada Inc. | Montreal | Novartis AG | BASEL | Switzerland | ||
Novartis Pharma Canada INC.Novartis Pharma Canada INC. | Mississauga, Canada | 280 | Paul Smyth | cibavision.ca | 2834 | Pharmaceutical Preparations | 564 | Novartis Pharma Canada Inc. | Montreal | Canada | Novartis Pharma Canada Inc. | Montreal | Novartis AG | BASEL | Switzerland | |||||
Novartis Pharma Canada INC.Novartis Pharma Canada INC. | Richmond, Canada | 1 | Anna Rossi | 2834 | Pharmaceutical Preparations | 564 | Novartis Pharma Canada Inc. | Montreal | Canada | Novartis Pharma Canada Inc. | Montreal | Novartis AG | BASEL | Switzerland | ||||||
Novartis Groupe FranceNovartis Groupe FranceNational HQ | Rueil-malmaison, France | 1970 | 6 | $2.0M | Corporation | Thibaut Victormichel | novartis.fr | 6719 | Offices of Holding Companies, Not Elsewhere Classified | 564 | Novartis AG | BASEL | Switzerland | NOVARTIS GROUPE FRANCE | RUEIL-MALMAISON | Novartis AG | BASEL | Switzerland | ||
Advanced Accelerator ApplicationsAdvanced Accelerator ApplicationsLocal HQ | Rueil-malmaison, France | 2002 | 63 | $199.4M | Corporation | Thibaut Marie Victor Michel | adacap.com | 2834 | Pharmaceutical Preparations | 564 | NOVARTIS GROUPE FRANCE | RUEIL-MALMAISON | France | NOVARTIS GROUPE FRANCE | RUEIL-MALMAISON | Novartis AG | BASEL | Switzerland | ||
Advanced Accelerator ApplicationsAdvanced Accelerator Applications | Saint-herblain, France | 2009 | 1 | Thibaut Marie Victor Michel | 2834 | Pharmaceutical Preparations | 564 | ADVANCED ACCELERATOR APPLICATIONS | RUEIL-MALMAISON | France | NOVARTIS GROUPE FRANCE | RUEIL-MALMAISON | Novartis AG | BASEL | Switzerland | |||||
Advanced Accelerator ApplicationsAdvanced Accelerator Applications | Saint-genis-pouilly, France | 2003 | 50 | Thibaut Marie Victor Michel | adacap.com | 2834 | Pharmaceutical Preparations | 564 | ADVANCED ACCELERATOR APPLICATIONS | RUEIL-MALMAISON | France | NOVARTIS GROUPE FRANCE | RUEIL-MALMAISON | Novartis AG | BASEL | Switzerland | ||||
Advanced Accelerator Applications (UK & Ireland) LIMITEDAdvanced Accelerator Applications (UK & Ireland) LIMITEDNational HQ | West Kensington, Unitedkingdom | 2001 | 9 | $17.5M | Corporation | Sandeep Gupta | 7359 | Equipment Rental and Leasing, Not Elsewhere Classified | 564 | ADVANCED ACCELERATOR APPLICATIONS | RUEIL-MALMAISON | France | ADVANCED ACCELERATOR APPLICATIONS (UK & IRELAND) LIMITED | LONDON | Novartis AG | BASEL | Switzerland | |||
I.D.B. Holland B.V.I.D.B. Holland B.V.National HQ | Baarle-nassau, Netherlands | 1982 | 54 | $1.3M | Corporation | Brett Miller | novartis.com | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 564 | ADVANCED ACCELERATOR APPLICATIONS | RUEIL-MALMAISON | France | I.D.B. Holland B.V. | Baarle Nassau | Novartis AG | BASEL | Switzerland | ||
Novartis Pharma SASNovartis Pharma SASLocal HQ | Rueil-malmaison, France | 1996 | 2,000 | $2.6B | Corporation | Thibaut Victormichel | novartis.fr | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 564 | NOVARTIS GROUPE FRANCE | RUEIL-MALMAISON | France | NOVARTIS GROUPE FRANCE | RUEIL-MALMAISON | Novartis AG | BASEL | Switzerland | ||
Novartis Pharma SASNovartis Pharma SAS | Huningue, France | 2011 | 500 | novartis.fr | 2834 | Pharmaceutical Preparations | 564 | NOVARTIS PHARMA SAS | RUEIL-MALMAISON | France | NOVARTIS GROUPE FRANCE | RUEIL-MALMAISON | Novartis AG | BASEL | Switzerland | |||||
Novartis Pharma SASNovartis Pharma SAS | Vandoeuvre-lès-nancy, France | 1997 | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 564 | NOVARTIS PHARMA SAS | RUEIL-MALMAISON | France | NOVARTIS GROUPE FRANCE | RUEIL-MALMAISON | Novartis AG | BASEL | Switzerland | |||||||
Novartis Pharma SASNovartis Pharma SAS | Clermont-ferrand, France | 1997 | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 564 | NOVARTIS PHARMA SAS | RUEIL-MALMAISON | France | NOVARTIS GROUPE FRANCE | RUEIL-MALMAISON | Novartis AG | BASEL | Switzerland | |||||||
Novartis Pharma SASNovartis Pharma SAS | Lyon, France | 1997 | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 564 | NOVARTIS PHARMA SAS | RUEIL-MALMAISON | France | NOVARTIS GROUPE FRANCE | RUEIL-MALMAISON | Novartis AG | BASEL | Switzerland | |||||||
Novartis Pharma SASNovartis Pharma SAS | Lyon, France | 1997 | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 564 | NOVARTIS PHARMA SAS | RUEIL-MALMAISON | France | NOVARTIS GROUPE FRANCE | RUEIL-MALMAISON | Novartis AG | BASEL | Switzerland | |||||||
Novartis Holding GMBHNovartis Holding GMBHNational HQ | Wien, Austria | 2022 | 4 | $160K | Corporation | Peter Gillich | 6719 | Offices of Holding Companies, Not Elsewhere Classified | 564 | Novartis AG | BASEL | Switzerland | Novartis Holding GmbH | Wien | Novartis AG | BASEL | Switzerland | |||
Novartis Pharma GMBHNovartis Pharma GMBH | Wien, Austria | 1967 | 243 | $337.4M | Corporation | Catherine Emond | novartis.at/ueber-uns/kontakt | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 564 | Novartis Holding GmbH | Wien | Austria | Novartis Holding GmbH | Wien | Novartis AG | BASEL | Switzerland | ||
Novartis Pharmaceutical Manufacturing GMBHNovartis Pharmaceutical Manufacturing GMBHLocal HQ | Unterlangkampfen, Austria | 2022 | 3,402 | $1.7B | Corporation | Stefan Steger | novartis.com/at-de/ueber-uns/standorte-oesterreich | 2834 | Pharmaceutical Preparations | 564 | Novartis Holding GmbH | Wien | Austria | Novartis Holding GmbH | Wien | Novartis AG | BASEL | Switzerland | ||
Novartis Pharmaceutical Manufacturing GMBHNovartis Pharmaceutical Manufacturing GMBH | Wien, Austria | novartis.at/ueber-uns/kontakt | 9999 | Nonclassifiable Establishments | 564 | Novartis Pharmaceutical Manufacturing GmbH | Langkampfen | Austria | Novartis Holding GmbH | Wien | Novartis AG | BASEL | Switzerland | |||||||
Novartis Real Estate GMBHNovartis Real Estate GMBH | Unterlangkampfen, Austria | 2024 | 1 | $71K | Corporation | Peter Gillich | 5399 | Miscellaneous General Merchandise Stores | 564 | Novartis Pharmaceutical Manufacturing GmbH | Langkampfen | Austria | Novartis Holding GmbH | Wien | Novartis AG | BASEL | Switzerland | |||
Novartis Sverige ABNovartis Sverige ABNational HQ | Kista, Sweden | 1949 | 100 | $202.6M | Corporation | Klas Niklas Bergvall | novartis.se | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 564 | Novartis AG | BASEL | Switzerland | Novartis Sverige AB | KISTA | Novartis AG | BASEL | Switzerland | ||
Novartis Finland OYNovartis Finland OYNational HQ | Esbo, Finland | 1966 | 86 | $106.6M | Corporation | Minna Kumpula | novartis.fi | 5122 | Drugs, Drug Proprietaries, and Druggists' Sundries | 564 | Novartis AG | BASEL | Switzerland | Novartis Finland Oy | ESPOO | Novartis AG | BASEL | Switzerland | ||
Novartis Gene Therapies Switzerland GMBHNovartis Gene Therapies Switzerland GMBHNational HQ | Finland | 2020 | 1 | $311K | Foreign company | 8731 | Commercial Physical and Biological Research | 564 | Novartis AG | BASEL | Switzerland | Novartis Gene Therapies Switzerland GmbH | Novartis AG | BASEL | Switzerland | |||||
Novartis ManufacturingNovartis ManufacturingNational HQ | Puurs, Belgium | 1962 | 953 | $297.4M | Corporation | Wouter Keymeulen | novartis.be | 2834 | Pharmaceutical Preparations | 564 | Novartis AG | BASEL | Switzerland | Novartis Manufacturing | Puurs-Sint-Amands | Novartis AG | BASEL | Switzerland | ||
Get 1,000 subsidiaries free
Novartis’s ownership network is one of more than 41 million corporate hierarchies in our company ownership database. It maps parent companies, subsidiaries and ultimate beneficial owners (UBO), showing how companies are structured and who owns whom, with verified data across 190+ countries and jurisdictions. Explore how the dataset works and request a tailored sample.
In Basel, Switzerland.
Novartis AG is publicly traded with no single majority shareholder.
Yes. Novartis AG is incorporated and headquartered in Switzerland (company no. CHE-101.242.954).
Novartis employs over 100,000 people worldwide.
Global data. Local insights.
Explore in-depth information on global company structures, subsidiaries, and corporate hierarchies through our latest expert articles and analyses.
A global ultimate in a corporate family refers to the highest-level parent company in a...
Company Registries in the EU & North America A practical guide for compliance, KYC and...
What Are Company Family Members? A company family members refers to a group of interrelated...
Corporate family tree
Understanding ownership is key to seeing how companies connect and operate. Our corporate hierarchy data helps you trace relationships between parent entities, subsidiaries, and shareholders, revealing control, structure, and risk within any global group. Whether you’re analysing Novartis or another multinational, this level of insight supports compliance checks, market research, and smarter CRM data management. With verified ownership records covering more than 380 million companies worldwide, CompanyData.com delivers a clear view of who owns who across industries and borders.
At CompanyData.com, each company profile – like Novartis – is mapped using our three-level hierarchy model: Global, National, and Local headquarters. This structure reveals how every entity fits into its wider corporate family.
Each entity is assigned a unique ID, allowing you to link subsidiaries to parent groups, trace ownership paths, and integrate the data across your own systems.
Control is determined by ownership. When a company owns more than fifty percent of another, we classify it as a controlled subsidiary. Our data focuses on these majority-controlled relationships to clearly represent corporate hierarchies. This approach provides a transparent view of complex ownership networks such as Novartis’s and can be applied to any multinational group.
This model helps identify the real decision makers within the Novartis Group, simplifies compliance checks, and supports M&A or risk analysis. By mapping each entity with verified ownership data, CompanyData.com enables users to navigate Novartis’s corporate hierarchy confidently and see how global companies are structured. With more than 41 million companies linked across 200 countries and jurisdictions, our platform delivers clarity and transparency to international teams working with complex corporate networks.

CompanyData.com supports global organizations that need verified insights into corporate ownership structures, from CRM enrichment and compliance workflows to market intelligence and analytics. We provide free evaluation samples; larger data samples (for example, up to 1,000 companies) are available to qualified corporate buyers with a defined use case and an active company website. If your primary need is contact or lead lists, please visit our Company Data Platform instead.
Tell us about your use case or data challenge, and our team will send you a tailored ownership data sample within 24 hours.
You can access Novartis company data through API, bulk files, or the Bold Platform. We create custom datasets based on your target countries, industries, and company profiles. After you share your criteria, our experts prepare a tailored dataset and send a free quote with record counts and sample data within 24 hours. Once approved, we deliver your data quickly in your preferred format — via Excel, API, bulk file, or directly in the Bold Platform.
If you need company data from any organization or industry, CompanyData.com provides complete global coverage. You’ll get accurate, verified business information across every country and sector. Simply tell us what you’re looking for, and our experts will prepare a custom dataset that fits your goals. Within 24 hours, you’ll receive a free quote, record count, and sample data. Once approved, we deliver your data fast — via Excel, API, bulk file, or directly in the Bold Platform.
The price of our Novartis company data varies based on your chosen details and delivery method. Whether you need a list of subsidiaries or a full dataset via API or bulk files, we offer flexible pricing to suit your needs. You can request a free quote and record count within 24 hours — our team will provide transparent pricing and a free sample of 10 company contacts. At CompanyData.com, you only pay for the verified global data you need.
At CompanyData.com, we offer secure and flexible payment options for purchasing company data, including credit cards, bank transfer, and PayPal. All payments are processed safely, and invoices are provided. For larger or ongoing access, we also support subscription billing and custom invoicing. Need a special arrangement? Contact our sales team — we’re happy to help.
At CompanyData.com, you can access detailed, verified data on Novartis AG and all its subsidiaries, updated daily. This includes company names, registration details, locations, industry classifications, financial indicators, and key contacts. Novartis operates worldwide with a network of 568 entities across 90 countries, including a significant presence in the United States (146), India (118), China (22), and Switzerland (29). You can download the data via the Bold Platform, API, or bulk file delivery. Our database offers 100% worldwide company coverage, ensuring complete and accurate insights.
At CompanyData.com, our data comes from verified global business sources to ensure accuracy and full coverage. We combine official registers, financial filings, LEI records, trusted partners, and verified company websites. All data is cross-checked and validated by our experts, ensuring it’s accurate, up-to-date, and GDPR-compliant.
Share your target market and we’ll provide a free quote along with a customized Novartis company revenue dataset — sample included. Call +31 20 705 236 or email sales@companydata.com. Ready to proceed? Simply respond to the quote, and CompanyData.com delivers your dataset in CSV or Excel typically within 24 hours.